Beau O. Van Driel

Amsterdam, NH 1081HV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial.

Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial.

Journal: Cardiovascular research

Published: November 29, 2024

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants.

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants.

Journal: International journal of molecular sciences

Published: December 27, 2022

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

Journal: Cells

Published: July 11, 2021

Tracing triggers of cardiac remodelling and heart failure.

Tracing triggers of cardiac remodelling and heart failure.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: June 11, 2021

Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers.

Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers.

Journal: International journal of molecular sciences

Published: March 21, 2021

Strength of patient cohorts and biobanks for cardiomyopathy research.

Strength of patient cohorts and biobanks for cardiomyopathy research.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: August 12, 2020

Drug repurposing in cardiology.

Drug repurposing in cardiology.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: May 08, 2020

Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?

Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?

Journal: JAMA cardiology

Published: June 13, 2019

Correction to: Extra energy for hearts with a genetic defect: ENERGY trial.

Correction to: Extra energy for hearts with a genetic defect: ENERGY trial.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: March 22, 2019

Extra energy for hearts with a genetic defect: ENERGY trial.

Extra energy for hearts with a genetic defect: ENERGY trial.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: February 16, 2019

Sex differences in hypertrophic cardiomyopathy: new insights.

Sex differences in hypertrophic cardiomyopathy: new insights.

Journal: Current opinion in cardiology

Published: February 13, 2019

Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy

Journal: Nederlands tijdschrift voor geneeskunde

Published: February 08, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026